These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17912584)

  • 1. Combined SPIO-gadolinium magnetic resonance imaging in cirrhotic patients: negative predictive value and role in screening for hepatocellular carcinoma.
    Guiu B; Loffroy R; Ben Salem D; Lepage C; Guiu S; Aho S; Jouve JL; Krausé D; Cercueil JP
    Abdom Imaging; 2008; 33(5):520-8. PubMed ID: 17912584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-contrast MRI (DC-MRI) in the study of the cirrhotic liver: utility of administering Gd-DTPA as a complement to examinations in which SPIO liver uptake and distribution alterations (SPIO-LUDA) are present and in the identification and characterisation of focal lesions.
    Macarini L; Marini S; Milillo P; Vinci R; Ettorre GC
    Radiol Med; 2006 Dec; 111(8):1087-102. PubMed ID: 17171525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
    Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
    AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-contrast magnetic resonance imaging of hepatocellular carcinoma after transarterial chemoembolization.
    Bolog N; Pfammatter T; Müllhaupt B; Andreisek G; Weishaupt D
    Abdom Imaging; 2008; 33(3):313-23. PubMed ID: 17483983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
    Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D
    Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of hepatocellular carcinoma by ferumoxides-enhanced MR imaging in cirrhosis: Incremental value of dynamic gadolinium-enhancement.
    Qayyum A; Thoeni RF; Coakley FV; Lu Y; Guay JP; Ferrell LD
    J Magn Reson Imaging; 2006 Jan; 23(1):17-22. PubMed ID: 16315209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma in cirrhotic liver: double-contrast-enhanced, high-resolution 3.0T-MR imaging with pathologic correlation.
    Yoo HJ; Lee JM; Lee MW; Kim SJ; Lee JY; Han JK; Choi BI
    Invest Radiol; 2008 Jul; 43(7):538-46. PubMed ID: 18580337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small (Golfieri R; Marini E; Bazzocchi A; Fusco F; Trevisani F; Sama C; Mazzella G; Cavuto S; Piscaglia F; Bolondi L
    Radiol Med; 2009 Dec; 114(8):1239-66. PubMed ID: 19697104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of double contrast MRI in diagnosis of hepatocellular carcinoma in patients with chronic liver diseases.
    Teerasamit W; Saiviroonporn P; Pongpaibul A; Korpraphong P
    J Med Assoc Thai; 2014 May; 97(5):540-7. PubMed ID: 25065095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria.
    Leoni S; Piscaglia F; Golfieri R; Camaggi V; Vidili G; Pini P; Bolondi L
    Am J Gastroenterol; 2010 Mar; 105(3):599-609. PubMed ID: 19935786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT.
    Kim YK; Kwak HS; Kim CS; Chung GH; Han YM; Lee JM
    Radiology; 2006 Feb; 238(2):531-41. PubMed ID: 16371577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
    Jang KM; Kim SH; Kim YK; Choi D
    Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR characterisation of dysplastic nodules and hepatocarcinoma in the cirrhotic liver with hepatospecific superparamagnetic contrast agents: pathological correlation in explanted livers.
    Macarini L; Milillo P; Cascavilla A; Scalzo G; Stoppino L; Vinci R; Moretti G; Ettorre G
    Radiol Med; 2009 Dec; 114(8):1267-82. PubMed ID: 19902328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of hepatocellular carcinoma: comparison of Gd-DTPA- and ferumoxides-enhanced MR imaging.
    Simon G; Link TM; Wörtler K; Doebereiner F; Schulte-Frohlinde E; Daldrup-Link H; Settles M; Rummeny EJ
    Eur Radiol; 2005 May; 15(5):895-903. PubMed ID: 15800773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography.
    Kim YK; Kwak HS; Han YM; Kim CS
    J Comput Assist Tomogr; 2007; 31(5):702-11. PubMed ID: 17895780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of ring enhancement in hepatocellular carcinoma on superparamagnetic iron oxide-enhanced T1-weighted images: an investigation into peritumoral Kupffer cells.
    Tanimoto A; Wakabayashi G; Shinmoto H; Okuda S; Kuribayashi S; Mukai M
    J Magn Reson Imaging; 2005 Mar; 21(3):230-6. PubMed ID: 15723373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of liver lesions with gadolinium-enhanced VIBE sequence in comparison with SPIO-enhanced MRI].
    Heim P; Steiner P; Schoder V; Dieckmann C; Kuhlencordt R; Adam G
    Rofo; 2003 Oct; 175(10):1376-83. PubMed ID: 14556107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodule-in-nodule appearance of hepatocellular carcinomas: comparison of gadolinium-enhanced and ferumoxides-enhanced magnetic resonance imaging.
    Goshima S; Kanematsu M; Matsuo M; Kondo H; Kato H; Yokoyama R; Hoshi H; Moriyama N
    J Magn Reson Imaging; 2004 Aug; 20(2):250-5. PubMed ID: 15269950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.